Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-26-005409

Chief Medical Officer acquired 61,963 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rizvi Syed Ali-aamir Chief Medical Officer 2026-02-11 Grant or award +61,963 407,874 D
Derivatives
Rizvi Syed Ali-aamir Chief Medical Officer 2026-02-11 Grant or award · Stock Option (right to buy) +93,037 93,037 D
Loading xslF345X05/form4.xml…